SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-095799
Filing Date
2015-03-18
Accepted
2015-03-17 20:41:30
Documents
5
Period of Report
2015-03-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d894488d8k.htm 8-K 15880
2 EX-1.1 d894488dex11.htm EX-1.1 217533
3 EX-99.1 d894488dex991.htm EX-99.1 9423
4 GRAPHIC g894488ex99_1pg001new.jpg GRAPHIC 23382
5 GRAPHIC g894488ex99_1pg002new.jpg GRAPHIC 8817
  Complete submission text file 0001193125-15-095799.txt   288845
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 15708552
SIC: 2834 Pharmaceutical Preparations